Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[knuts4oe]

When MYMD Pharma's website was last available they said they had presented their Investigational New Drug (IND) MYMD-1 to the FDA in a Phase 1 trial to demonstrate its safety and determine probable dosages for the treatment of Hashimoto's Thyroiditis. They indicated that the Phase 1 trial should be completed in 2019.

They also indicated that ongoing preclinical studies focused on age-related diseases, virtually all autoimmune diseases, Alzheimer's disease, various cancers, and heart disease were being expanded.

No wonder that some of us here are chomping at the bit to see the MYMD website reopened!